Enagas SA
F:EG40
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Enagas SA
F:EG40
|
ES |
|
Voyageur Pharmaceuticals Ltd
XTSX:VM
|
CA |
Wall St Price Targets
EG40 Price Targets Summary
Enagas SA
According to Wall Street analysts, the average 1-year price target for EG40 is 8.35 EUR with a low forecast of 6.16 EUR and a high forecast of 10.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EG40's stock price target?
Price Target
8.35
EUR
According to Wall Street analysts, the average 1-year price target for EG40 is 8.35 EUR with a low forecast of 6.16 EUR and a high forecast of 10.51 EUR.
What is the Revenue forecast for Enagas SA?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 5 years is 1%.
What is the Gross Profit forecast for Enagas SA?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Enagas SA?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 5 years is 11%.
What is the Pre-Tax Income forecast for Enagas SA?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is -6%.
What is the Net Income forecast for Enagas SA?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 5 years is -3%.
